mTREC levels in allogeneic full-term fetal blood recipients compared with T-cell–depleted bone marrow recipients
| Groups . | n . | mTRECs/100 000 cells . | |
|---|---|---|---|
| CD4 . | CD8 . | ||
| Normal C57BL/6 | 3 | 9860 ± 4878 | 8072 ± 1586 |
| Allogeneic T-cell–depleted bone marrow | 5 | 13 825 ± 3721 | 9604 ± 2771 |
| Allogeneic full-term fetal blood | 4 | 3092 ± 9024-150 | 2605 ± 2284-150 |
| Groups . | n . | mTRECs/100 000 cells . | |
|---|---|---|---|
| CD4 . | CD8 . | ||
| Normal C57BL/6 | 3 | 9860 ± 4878 | 8072 ± 1586 |
| Allogeneic T-cell–depleted bone marrow | 5 | 13 825 ± 3721 | 9604 ± 2771 |
| Allogeneic full-term fetal blood | 4 | 3092 ± 9024-150 | 2605 ± 2284-150 |
Spleen cells were obtained 200 days after transplantation. The methods for quantification of mTRECs can be found in “Materials and methods.”
mTRECs indicates mouse T-cell receptor signal joint excision circles.
P < .05, compared to other groups.